Yankees Score with ...
Health Care: Drugs
Talecris Biotherapeutics Inc. (TLCR: NASDAQ)
$28.80 0.00 | 0.00%
07/30/12 - 12:15 AM ET
0.00 / 1.04M
Vol / Avg. Vol:28.80 / 28.80
Open / Prev. Close:28.80 - 28.80
Today's Range:20.87 - 29.00
52 Wk Range:23.61%
Performance YTD:TheStreet Rating:
Portfolios with TLCR
- Portfolio NameUser Type
- UserSW Investments
- UserPART 5 JPMorgan 28th Annual...
- UserJAMERSON
Latest TLCR Headlines from TheStreet
- Talecris Reaches New 52-Week High (TLCR) 05.02.11 | 10:05 am
- Talecris Stock Hits New 52-Week High (TLCR) 04.14.11 | 11:04 am
- Talecris Stock Hits New 52-Week High (TLCR) 04.04.11 | 11:04 am
- Talecris Stock Hits New 52-Week High (TLCR) 03.24.11 | 10:03 am
- Talecris Stock Hits New 52-Week High (TLCR) 03.04.11 | 10:03 am
- Talecris Stock Hits New 52-Week High (TLCR) 02.22.11 | 10:02 am
- Talecris Stock Falls On Unusually High Volume (TLCR) 02.15.11 | 03:02 pm
- BP, Apple: Monday's Headlines 06.07.10 | 08:06 am
- Bears Ride the Slide 06.07.10 | 05:06 am
- Talecris To Be Acquired for $3.4 Billion 06.07.10 | 04:06 am
Press Releases for TLCR
- Grifols And Talecris Biotherapeutics Announce The FTC Has Accepted The Consent Agreement For Public Comment - PR Newswire 06.01.11 | 06:06 am
- Talecris Biotherapeutics Announces Results Of Annual Stockholders' Meeting - PR Newswire 05.03.11 | 11:05 am
- Grifols And Talecris Biotherapeutics Announce The Signing Of A Consent Agreement With FTC Staff - PR Newswire 05.02.11 | 06:05 am
- Talecris Biotherapeutics To Report First Quarter 2011 Financial Results - PR Newswire 04.14.11 | 09:04 am
- Talecris Biotherapeutics Announces Record Date For 2011 Annual Meeting Of Shareholders - PR Newswire 03.04.11 | 04:03 pm
- Grifols And Talecris Announce The Outside Date Of Their Merger Agreement Has Been Extended To June 30, 2011 - PR Newswire 03.04.11 | 08:03 am
- Talecris Biotherapeutics Receives EU Orphan Drug Designation For Plasmin (Human) As A Treatment For Acute Peripheral Arterial Occlusion - PR Newswire 03.03.11 | 02:03 pm
- NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision On Grifols Acquisition - PR Newswire 02.15.11 | 09:02 am
- Talecris Shareholders Approve Merger With Grifols During Special Meeting Of Shareholders - PR Newswire 02.14.11 | 05:02 pm
- Talecris Biotherapeutics To Report Fourth Quarter And Full Year 2010 Financial Results - PR Newswire 02.08.11 | 01:02 pm
Partner Headlines for TLCR
- Baxter Beats Fair and Square - Analyst Blog - Zacks 04.21.11 | 08:04 pm
- Earnings Preview: Baxter - Analyst Blog - Zacks 04.18.11 | 10:04 am
- Talecris Biotherapeutics Holdings Corp. - Momentum - Zacks 04.18.11 | 01:04 am
- Merger Arbitrage Mondays: March 07, 2011 - Seeking Alpha 03.07.11 | 09:03 am
- Earnings Preview: Baxter - Analyst Blog - Zacks 01.25.11 | 09:01 am
- Options Brief: Talecris Biotherapeutics (TLCR) - Benzinga 01.21.11 | 01:01 pm
- 12 Quality Stocks In An Uptrend That Remain Undervalued - Seeking Alpha 09.03.10 | 11:09 am
- 6 Overbought Stocks Reporting Earnings on July 29 - Seeking Alpha 07.29.10 | 07:07 am
- Merger Arbitrage Mondays: June 14, 2010 - Seeking Alpha 06.14.10 | 09:06 am
- Grifols' Talecris Package Leads a Hot Week for Life Sciences Deals - Seeking Alpha 06.13.10 | 06:06 am
